CHARLESTON, S.C., Nov. 9, 2011 /PRNewswire/ -- VaxyGen Assay Services, LLC, today announced that it has commenced business operations, providing custom assay services, immunoassays, and database services in support of biopharmaceutical and vaccine development. The Company offers customized solutions to meet basic, applied, and clinical research demands, providing unique in vitro assays in support of research and development of novel biopharmaceutical and vaccine products operating through its GLP compliant laboratory facilities to support biomarker/immunoassay evaluation and development needs.
Commenting on the launch of VaxyGen Assay Services, David Dodd, CEO, stated, "We believe that our clients are best served through the successful combination of the highest expertise and support of science and business. Our clients are committed to delivering innovative, life enhancing products. VaxyGen Assay Services was founded to ensure that our clients can consistently rely on us to deliver them the highest quality client service and scientific service in support of their biological assay service needs. Our Management Team reflects this commitment – most importantly, through their demonstrated experience in delivering such value to clients."
Leading the scientific and technical expertise at VaxyGen Assay Services is Joseph E. Martinez, Ph.D., a recognized expert in flow cytometry and multiplexed immunoassay development. Joseph is a research biologist with 25 years of flow cytometry experience. Prior to the formation of the VaxyGen family of companies, he spent 13 years as the head of the flow cytometry laboratory within the Respiratory Diseases Section at the Centers for Disease Control and Prevention. He has served as the Director of Research and Laboratory Services for se
|SOURCE VaxyGen Assay Services, LLC|
Copyright©2010 PR Newswire.
All rights reserved